ホーム > 鈴木 裕之/ Suzuki, Hiroyuki

鈴木 裕之

ALUMNI 2025年3月現在、筑波大学が主たる所属機関ではありません

Suzuki, Hiroyuki

東北大学 , 大学院医学系研究科 , 准教授
Tohoku University , Graduate School of Medicine , Associate Professor

http://www.md.tsukuba.ac.jp/epatho/

http://www.md.tsukuba.ac.jp/younginit/

オープンアクセス版の論文は「つくばリポジトリ」で読むことができます。
  1. 1. A novel anti-mouse CXCR1 monoclonal antibody, Cx1Mab-8, demonstrates nanomolar affinity in flow cytometry. Guanjie Li; Hiroyuki Suzuki; Tomohiro Tanaka; Hiroyuki Satofuka (+1 著者) Yukinari Kato
      Biochemistry and biophysics reports 42: 101965 (2025)
  2. 2. A novel anti-mouse CCR7 monoclonal antibody, C7Mab-7, demonstrates high sensitivity in flow cytometry, western blot, and immunohistochemistry. Hiroyuki Satofuka; Hiroyuki Suzuki; Tomohiro Tanaka; Rena Ubukata (+6 著者) Yukinari Kato
      Biochemistry and biophysics reports 41: 101948 (2025)
  3. 3. THG-1/TSC22D4 promotes interleukin-1 signaling through stabilization of TRAF6 in squamous cell carcinoma. Yasuhito Okano; Hiroyuki Suzuki; Yukihide Watanabe; Mohammed Abdelaziz (+14 著者) Mitsuyasu Kato
      Molecular cancer research : MCR (2025)
  4. 4. Antitumor Activities of a Humanized Cancer-Specific Anti-HER2 Monoclonal Antibody, humH2Mab-250 in Human Breast Cancer Xenografts. Mika K Kaneko; Hiroyuki Suzuki; Tomokazu Ohishi; Takuro Nakamura (+2 著者) Yukinari Kato
      International journal of molecular sciences 26: (2025)
  5. 5. Development of specific anti-mouse atypical chemokine receptor 4 monoclonal antibodies. Miu Hirose; Hiroyuki Suzuki; Rena Ubukata; Tomohiro Tanaka (+1 著者) Yukinari Kato
      Biochemistry and biophysics reports 40: 101824 (2024) Semantic Scholar
  6. 6. A Cancer-Specific Anti-Podoplanin Monoclonal Antibody, PMab-117-mG2a Exerts Antitumor Activities in Human Tumor Xenograft Models. Tomohiro Tanaka; Hiroyuki Suzuki; Tomokazu Ohishi; Mika K KanekoYukinari Kato
      Cells 13: (2024) Semantic Scholar
  7. 7. A Cancer-Specific Anti-Podoplanin Monoclonal Antibody, PMab-117-mG2a Exerts Antitumor Activities in Human Tumor Xenograft Models Tomohiro Tanaka; Hiroyuki Suzuki; Tomokazu Ohishi; Mika K. KanekoYukinari Kato
      Cells 13: 1833 (2024) Semantic Scholar
  8. 8. Antitumor activities of anti‑CD44 monoclonal antibodies in mouse xenograft models of esophageal cancer Kenichiro Ishikawa; Hiroyuki Suzuki; Tomokazu Ohishi; Takuro Nakamura (+7 著者) Yukinari Kato
      Oncology Reports 52: (2024) Semantic Scholar
  9. 9. Anti-CD44 Variant 10 Monoclonal Antibody Exerts Antitumor Activity in Mouse Xenograft Models of Oral Squamous Cell Carcinomas Kenichiro Ishikawa; Hiroyuki Suzuki; Tomokazu Ohishi; Guanjie Li (+5 著者) Yukinari Kato
      International Journal of Molecular Sciences 25: 9190 (2024) Semantic Scholar
  10. 10. Anti-HER2 Cancer-Specific mAb, H2Mab-250-hG1, Possesses Higher Complement-Dependent Cytotoxicity than Trastuzumab. Hiroyuki Suzuki; Tomokazu Ohishi; Tomohiro Tanaka; Mika K KanekoYukinari Kato
      International journal of molecular sciences 25: (2024) Semantic Scholar
  11. 11. Development of Sensitive Anti-Mouse CCR5 Monoclonal Antibodies Using the N-Terminal Peptide Immunization. Rena Ubukata; Hiroyuki Suzuki; Tomohiro Tanaka; Guanjie Li (+1 著者) Yukinari Kato
      Monoclonal antibodies in immunodiagnosis and immunotherapy (2024) Semantic Scholar
  12. 12. Development of a Sensitive Anti-Mouse CCR5 Monoclonal Antibody for Flow Cytometry. Hiroyuki Suzuki; Tomohiro Tanaka; Guanjie Li; Tsunenori Ouchida (+1 著者) Yukinari Kato
      Monoclonal antibodies in immunodiagnosis and immunotherapy (2024) Semantic Scholar
  13. 13. Epitope Mapping of an Anti-CD44v4 Monoclonal Antibody (C44Mab-108) Using Enzyme-Linked Immunosorbent Assay Hiroyuki Suzuki; Mayuki Tawara; Aoi Hirayama; Nohara Goto (+2 著者) Yukinari Kato
      Monoclonal Antibodies in Immunodiagnosis and Immunotherapy 43: 85 (2024)
  14. 14. PMab-314: An Anti-Giant Panda Podoplanin Monoclonal Antibody. Tsunenori Ouchida; Guanjie Li; Hiroyuki Suzuki; Miyuki Yanaka (+4 著者) Yukinari Kato
      Monoclonal antibodies in immunodiagnosis and immunotherapy 43: 53 (2024) Semantic Scholar
  15. 15. Cx1Mab-1: A Novel Anti-mouse CXCR1 Monoclonal Antibody for Flow Cytometry. Guanjie Li; Tomohiro Tanaka; Tsunenori Ouchida; Mika K Kaneko (+1 著者) Yukinari Kato
      Monoclonal antibodies in immunodiagnosis and immunotherapy 43: 59 (2024) Semantic Scholar
  16. 16. Cx3Mab-4: A Novel Anti-Mouse CXCR3 Monoclonal Antibody for Flow Cytometry. Tsunenori Ouchida; Yu Isoda; Tomohiro Tanaka; Mika K Kaneko (+1 著者) Yukinari Kato
      Monoclonal antibodies in immunodiagnosis and immunotherapy (2024)
  17. 17. Epitope Mapping of an Anti-Mouse CD39 Monoclonal Antibody Using PA Scanning and RIEDL Scanning. Yuki Okada; Hiroyuki Suzuki; Tomohiro Tanaka; Mika K KanekoYukinari Kato
      Monoclonal antibodies in immunodiagnosis and immunotherapy (2024) Semantic Scholar
  18. 18. Glycoprotein nonmetastatic melanoma protein B impacts the malignant potential of bladder cancer cells through its hem-immunoreceptor tyrosine-based activation motif. Tomokazu Kimura; Yukari Okita; Yoshiyuki Nagumo; Jas Min Chin (+6 著者) Mitsuyasu Kato
      Pathology international (2024) Semantic Scholar
  19. 19. C8Mab-21: A Novel Anti-human CCR8 Monoclonal Antibody for Flow Cytometry Tomohiro Tanaka; Hiroyuki Suzuki; Guanjie Li; Mika K KanekoYukinari Kato
      (2024)
  20. 20. Locally misfolded HER2 expressed on cancer cells is a promising target for development of cancer-specific antibodies Takao Arimori; Emiko Mihara; Hiroyuki Suzuki; Tomokazu Ohishi (+3 著者) Yukinari Kato
      Structure (2024) Semantic Scholar
1 2 3 … 9
  1. 1. あなたのラボから薬を生み出すアカデミア創薬の実践 : all Japan体制の先端技術支援を利用した創薬の最前線 善光, 龍哉; 辻川, 和丈 (担当:分担執筆, 範囲:CBIS法による高感度抗体の作製)
    羊土社 2024年2月 (ISBN: 9784758104166)
  2. 2. がんゲノム医療時代の分子腫瘍学 鈴木裕之; 後藤のはら; 加藤光保 (担当:分担執筆, 範囲:TGF-β経路)
    文光堂 2022年4月
  3. 3. 炎症メディエーター TGF-β 鈴木,裕之; 青山,知恵; 加藤,光保 (担当:共著)
    日本臨床 2009年5月
  4. 4. TGF-betaシグナル伝達系とがん治療 鈴木裕之; 中条友香; 加藤光保 (担当:監修)
    南山堂 2008年9月
  5. 5. TGF-βシグナル伝達とがん治療 鈴木裕之; 中条友香; 加藤光保 (担当:分担執筆)
    がんの分子標的治療 2008年6月
  6. 6. Negative regulation of the TGF-β family signal pathway by inhibitory Smads and their involvement in cancer and fibrosis. Itoh S; Suzuki H; Itoh F; Miyazono K; Kato M (担当:共著)
    Humana Press Inc. 2008年
  7. 7. IGFBP 鈴木裕之; 加藤光保 (担当:監修)
    サイトカイン・増殖因子用語ライブラリー / 羊土社 2005年3月
  8. 8. TGF-betaシグナルと疾患 鈴木裕之; 宮園浩平 (担当:監修)
    シグナル伝達研究2003 シグナル伝達研究2003 羊土社 2003年1月
  1. 1. THG-1 overexpression stabilizes β-catenin via antagonizing NRBP1 in esophageal squamous cell carcinoma Hwang, Jongchan; Suzuki, Hiroyuki; Zhang, Jing; Vasudevan, Prasanna; Dijke, Peter ten; Kato, Mitsuyasu
    第79回日本癌学会学術総会 2020年10月1日
  2. 2. THG-1/TSC22D4による細胞老化の制御 鈴木裕之; 加藤光保
    第79回日本癌学会学術総会 2020年10月1日
  3. 3. THG-1はHIF-1alphaの安定化を介して腫瘍の進行を促進する 鄭齢; 加藤, 光保; 鈴木裕之
    第3回がん三次元培養研究会 2019年11月18日
  4. 4. Regulation of c-MYC transcriptional activity by transforming growth factor-beta 1–stimulated clone 22 Suzuki, SHiroyuki; Kato, Mitsuyasu
    第78回日本癌学会学術総会 2019年9月26日
  5. 5. Screening of macrocyclic peptide against CD44 Goto, Nohara; HIPOLITO; CHRISTOPHER; Suzuki, Hiroyuki; Kato, Mitsuyasu
    第78回日本癌学会学術総会 2019年9月26日
  6. 6. Oncogenic functions of TGFβ-stimulated clone-22 families
    STINT Special Symposium on the Sweden-Japan 150 Anniversary Grant 2019年1月19日 招待有り
  7. 7. Screening of macrocyclic peptide against CD44s Goto, Nohara; Yin, Yizhen; Hipolito, Christopher John; Suzuki, Hiroyuki; Suga, Hiroaki; Kato, Mitsuyasu; Heldin, Paraskevi; Constantinos Kolliopoulos; Karalis, Theodoros
    第10回国際ペプチドシンポジウム／第55回ペプチド討論会 2018年12月3日
  8. 8. THG-1, a novel oncogene in tumor angiogenesis Zheng, Ling; Suzuki, Hiroyuki; Kato, Mitsuyasu
    第41回日本分子生物学会年会 2018年11月28日
  9. 9. 乳がん細胞におけるGPNMBの幹細胞性誘導作用 沖田結花里; 陳晨; 鈴木裕之; 加藤, 光保
    第77回日本癌学会学術総会 2018年9月27日
  10. 10. 扁平上皮がん進展におけるTHG-1/Tsc22D4の機能 鈴木裕之; 加藤, 光保
    第77回日本癌学会学術総会 2018年9月27日
  11. 11. 3D imaging analysis of the promotion process from beta -catenin accumulated crypts to colonic adenomas in mice model Kase, Kazuo; Saito, Nobuko; Iwasaki, Hideaki; Hiroshima, Kenzo; Okita, Yukari; Watanabe, Yukihide; Suzuki, Hiroyuki; Kato, Mitsuyasu
    日本癌学会学術総会 2018年9月27日
  12. 12. Roles of the interaction between THG-1 and NRBP1 in the development of esophageal squamous cell carcinoma Hwang, Jongchan; Miura, Mayuka; Suzuki, Hiroyuki; Djike, Peter ten; Kato, Mitsuyasu
    Tsukuba Global Science Week 2018 2018年9月20日
  13. 13. 扁平上皮がんの発生病理 鈴木裕之
    第104回日本病理学会総会 2016年 招待有り
  14. 14. Roles of THG-1/Tsc22D4 in squamous cell carcinoma development Hiroyuki Suzuki
    Tsukuba-UCI Science Partnership Conference 2015年12月10日
  15. 15. Roles of THG-1/Tsc22D4 in squamous cell carcinoma development Hiroyuki Suzuki
    Joint International Symposium on TGF-family and Cancer 2015年1月12日 招待有り
  16. 16. Hypoxia and oxidative stress resistance in squamous cell carcinoma Hiroyuki Suzuki
    Annual meeting of Hypoxia 2014年11月22日 招待有り
  17. 17. Roles of THG-1/Tsc22D4 in tumor development Hiroyuki Suzuki
    TGF-beta meeting, Netherland 2014 2014年5月9日
  18. 18. Roles of THG-1/Tsc22D4 in tumorigenesis Hiroyuki Suzuki
    TGF-beta meeting, Sweden, 2013 2013年
  19. 19. TGF-β suppresses transcription of HO-1 gene through induction of MafK and Bach1. Yukari,Okita; Hiroyuki,Suzuki; Mitsuyasu,Kato
    Leading Graduate Schools International Conference 2010年11月1日
  20. 20. Tsc-22 and TMEPAI; target genes of TGF-beta signaling possibly involved in cancer development Kato, M; Suzuki, H; Watanabe.Y; Itoh.S
    *EMPTY*____ 2007年9月
1 2

 1,498 total views